OncoSec Medical (FRA:ONMA) Total Stockholders Equity : €-5.09 Mil (As of Jan. 2023)

View and export this data going back to 2015. Start your Free Trial

What is OncoSec Medical Total Stockholders Equity?

OncoSec Medical's Total Stockholders Equity for the quarter that ended in Jan. 2023 was €-5.09 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. OncoSec Medical's Book Value per Share for the quarter that ended in Jan. 2023 was €-1.71. The ratio of a company's debt over equity can be used to measure how leveraged this company is. OncoSec Medical's Debt-to-Equity for the quarter that ended in Jan. 2023 was -0.63.

OncoSec Medical Total Stockholders Equity Historical Data

The historical data trend for OncoSec Medical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoSec Medical Total Stockholders Equity Chart

OncoSec Medical Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Total Stockholders Equity

Get a 7-Day Free Trial

19.62

21.66

12.07

32.21

6.01

OncoSec Medical Quarterly Data
	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23
Total Stockholders Equity	Get a 7-Day Free Trial															17.52	12.86	6.01	-1.00	-5.09

OncoSec Medical (FRA:ONMA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

OncoSec Medical's Book Value per Share for the quarter that ended in Jan. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-5.091	-	0)	/	2.9712
	=	-1.71

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

OncoSec Medical's Debt-to-Equity for the quarter that ended in Jan. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.242	+	1.974)	/	-5.091
	=	-0.63

OncoSec Medical Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of OncoSec Medical's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoSec Medical (FRA:ONMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoSec Medical Inc (FRA:ONMA) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ONCSQ:USA

Address

24 North Main Street, Pennington, NJ, USA, 08534

Website

https://www.oncosec.com

OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.

OncoSec Medical (FRA:ONMA) Headlines

No Headlines